Vericel Corp logo

Vericel Corp

$ 23.75 -1.15 (-4.62%) 08:08 PM EST
On watch
P/E:
At Loss
P/B:
6.10
Market Cap:
$ 1.12B
Enterprise V:
$ 1.12B
Volume:
488.88K
Avg Vol (2M):
449.44K
Also Trade In:
Volume:
488.88K
Market Cap $:
1.12B
PE Ratio:
At Loss
Avg Vol (2-Month):
449.44K
Enterprise Value $:
1.12B
PB Ratio:
6.10
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 2.09
Equity-to-Asset 0.71
Debt-to-Equity 0.28
Debt-to-EBITDA -3.61
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.83
Distress
Grey
Safe
Beneish M-Score -3.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.87
9-Day RSI 41.59
14-Day RSI 41.95
6-1 Month Momentum % -33.45
12-1 Month Momentum % -45.35

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.2
Quick Ratio 5.56
Cash Ratio 4.03
Days Inventory 96.42
Days Sales Outstanding 76.94
Days Payable 55.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.5

Financials (Next Earnings Date:2022-11-09 Est.)

VCEL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VCEL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 155.217
EPS (TTM) ($) -0.36
Beta 2.29
Volatility % 54.53
14-Day RSI 41.95
14-Day ATR ($) 1.413984
20-Day SMA ($) 24.6715
12-1 Month Momentum % -45.35
52-Week Range ($) 22.06 - 52.87
Shares Outstanding (Mil) 47.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vericel Corp Filings

Document Form Filing Date
No Filing Data

Vericel Corp Analysis

Share your research

Headlines

See More
No news.